Search

everythinglearnresearchcommunity

for

Search:↓

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Women with PCOS are more likely to have sleep apnea, mainly if they are obese.

Flutamide reduces hair growth better but has more side effects.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Insulin resistance is significantly linked to a higher risk of depression in women with PCOS.

Melatonin improved mental health and metabolism in women with PCOS.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Hormonal therapies are safe and effective for treating adult women's acne.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

A simplified scoring system can effectively diagnose hirsutism in Chinese women of reproductive age.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.